Abstract

Background/objectivesBone-derived fibroblast growth factor 23 (FGF23) is a hormone that suppresses renal phosphate reabsorption and calcitriol (i.e., 1,25(OH)2D3) formation together with its co-receptor Klotho. FGF23- or Klotho-deficient mice suffer from rapid aging with multiple age-associated diseases, at least in part due to massive calcification. FGF23 is considered as a disease biomarker since elevated plasma levels are observed early in patients with acute and chronic disorders including renal, cardiovascular, inflammatory, and metabolic diseases. An energy-dense diet, which induces sequelae of the metabolic syndrome in humans and mice at least in part by enhancing pro-inflammatory TNFα formation, has recently been demonstrated to stimulate FGF23 production.MethodsWe investigated the relevance of TNFα for high-fat diet (HFD)-induced FGF23 formation in wild-type (tnf+/+) and TNFα-deficient (tnf−/−) mice.ResultsWithin 3 weeks, HFD feeding resulted in a strong increase in the serum FGF23 level in tnf+/+ mice. Moreover, it caused low-grade inflammation as evident from a surge in hepatic Tnfα transcript levels. TNFα stimulated Fgf23 transcription in UMR106 osteoblast-like cells. Serum FGF23 was significantly lower in tnf−/− mice compared to tnf+/+ mice following HFD. Serum phosphate and calcitriol were not significantly affected by genotype or diet.ConclusionsWe show that HFD feeding is a powerful stimulator of murine FGF23 production through TNFα formation.

Highlights

  • The hormone fibroblast growth factor 23 (FGF23) is mainly produced by osteoblasts and osteocytes in the bone[1]

  • We investigated the relevance of TNFα for high-fat diet (HFD)-induced FGF23 formation in wild-type and TNFα-deficient mice

  • Within 3 weeks, HFD feeding resulted in a strong increase in the serum FGF23 level in tnf+/+ mice

Read more

Summary

Introduction

The hormone fibroblast growth factor 23 (FGF23) is mainly produced by osteoblasts and osteocytes in the bone[1]. Its renal effects include inhibition of phosphate reabsorption and calcitriol formation[1, 2]. The renal effects of FGF23 are mediated by a receptor which requires the Klotho was originally discovered in 1997 as an antiaging protein[3,4,5]. Klotho-deficient mice have an extremely short life span of a few weeks only and exhibit many disorders associated with aging in humans[3]. FGF23deficient mice have a similar phenotype[6]. Both mouse strains suffer from drastically elevated plasma levels of phosphate and calcitriol due to the primary renal effect of FGF23 and Klotho. The premature aging of Klotho- or FGF23-deficient mice is a direct or indirect consequence of the hyperphosphatemia of the Nutrition and Diabetes

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call